Facebook Pixel pimecrolimus topical - WellSpan Health Library Document - WellSpan Health
Print view logo


pimecrolimus topical

Pronunciation: PIM e KROE li mus TOP ik al

Brand: Elidel

What is the most important information I should know about pimecrolimus topical?

This medicine is not for long-term use. A small number of people using pimecrolimus or tacrolimus skin medications have developed skin cancer or lymphoma. However, it is not known if either of these medicines causes cancer.

Use this medicine only on skin that is affected by eczema. Avoid applying to an area that may be affected with skin cancer.

What is pimecrolimus topical?

Pimecrolimus topical (for the skin) is used short term to treat mild to moderate eczema in adults and children at least 2 years old.

This medicine is not for use in people who have a weak immune system.

Pimecrolimus may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before using pimecrolimus topical?

You should not use pimecrolimus if you are allergic to it.

Not approved for anyone younger than 2 years old.

Tell your doctor if you have ever had:

  • skin cancer;
  • a bacterial or viral skin infection (including herpes or chickenpox);
  • Netherton's syndrome (a genetic skin disorder); or
  • a weak immune system (caused by disease or by using certain medicine).

A small number of people using pimecrolimus or tacrolimus skin medications have developed skin cancer or lymphoma. However, it is not known if either of these medicines causes cancer. Ask your doctor about your risk.

It is not known if pimecrolimus topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Do not breastfeed.

How should I use pimecrolimus topical?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Do not take by mouth. Topical medicine is for use only on the skin.

Wash your hands before and after applying this medicine, unless you are treating eczema on your hands. If you are applying the medicine to another person, wash your hands with soap and water afterward.

Apply a thin layer of pimecrolimus topical to clean, dry skin and rub in gently. Use the smallest amount needed to control the symptoms of eczema.

Use this medicine only on skin that is affected by eczema. Avoid applying to an area that may be affected with skin cancer.

Right after applying pimecrolimus, you may need to use a moisturizing cream or lotion to keep your skin from getting too dry. Ask your doctor about which cream or lotion to use.

Do not cover treated skin with a bandage unless your doctor tells you to.

Do not bathe, shower, or swim right after applying pimecrolimus topical. Water may wash off the medicine.

Call your doctor if your symptoms do not improve after 6 weeks.

Pimecrolimus topical is not for long-term use. Stop using this medicine when symptoms of eczema clear up, unless your doctor has told you otherwise. You may need to take a short break from using pimecrolimus topical if you need to repeat this treatment.

You may get viral infections more easily, such as chickenpox or herpes (cold sores or shingles).

Store at room temperature. Do not freeze.

What happens if I miss a dose?

Apply the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not apply two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medicine.

What should I avoid while using pimecrolimus topical?

Avoid getting this medicine in your eyes, nose, mouth, rectum, or vagina. If this does happen, wipe off the cream and rinse the area with cold water.

Avoid sunlight, tanning beds, and phototherapy treatments with ultraviolet light. Wear loose clothing over treated skin. Ask your doctor before using sunscreen on treated skin.

Do not share this medicine with another person, even if they have the same symptoms you have.

Drinking alcohol while using this medicine can cause warmth, flushing, or redness in your skin or face.

Avoid using other medications on the areas you treat with pimecrolimus topical unless your doctor tells you to.

What are the possible side effects of pimecrolimus topical?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • severe pain, burning, itching, or stinging;
  • new or worsened skin symptoms (warts, unusual rash or skin lesions, blistering or oozing);
  • a mole that has changed in size or color; or
  • symptoms of a viral skin infection --cold sores around your mouth, skin sores or blisters, scabs, itching, tingling.

Common side effects may include:

  • burning, stinging, or soreness of treated skin (especially during the first few days of treatment);
  • viral skin infection;
  • runny or stuffy nose;
  • headache; or
  • fever, chills, body aches, sore throat, cough, swollen glands.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect pimecrolimus topical?

Other drugs may affect pimecrolimus topical, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Where can I get more information?

Your pharmacist can provide more information about pimecrolimus topical.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2022 Cerner Multum, Inc. Version: 6.01. Revision date: 11/2/2021.

Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by End-User License Agreement, which can be accessed by clicking on this link.

Research Health Topics

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Search Content: